Xenter Unveils Groundbreaking Investigational Dual Sensor Wireless GuideWire for Minimally Invasive TAVR Procedures at TCT 2023
Revolutionizing Data Collection in Cardiology with Proprietary Wireless Ecosystem November 08, 2023 09:00 AM Eastern Standard Time DRAPER, Utah–(BUSINESS WIRE)–Xenter, Inc. (Xenter.io) announced the recent unveiling of its groundbreaking dual sensor investigational guidewire for TAVR procedures at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference in San Francisco, CA. Xenter introduced the first-of-its-kind wireless guidewire designed […]
MEDIA ALERT — Nov. 15, 2022
11:30am on Thursday, Nov. 17, 2022: Utah Valley University Presidential Lecture Series will feature Keynote Speaker Elazer R. Edelman, M.D., Ph.D. (world renowned cardiologist, biomedical engineer, and board member of Draper, Utah-based Xenter) WHO: Elazer R. Edelman, M.D., Ph.D. is a cardiovascular medicine specialist at Brigham and Women’s Hospital, a professor of medicine at […]
Florida’s Palm Vascular Centers is the First Healthcare Organization to Install XenFI, the Recently Announced Wireless Medical Ecosystem from Xenter
DRAPER, Utah — November 02, 2022 —Florida-based Palm Vascular Centers is the first healthcare organization to deploy XenFI™, the recently announced wireless medical ecosystem from Utah-based Xenter™. XenFI is the first step in a planned series of digital applications from Xenter that combine conversational voice recognition software, artificial intelligence (AI), machine learning (ML), and clinical […]
Xenter, the World’s First “TechMed” Company, Unveils the XenFI Wireless Network
DRAPER, Utah — October 05, 2022 — In an effort to improve the adoption of new technology in healthcare, Xenter™ today unveiled XenFI™, the first product in its wireless “Technology in Medicine” ecosystem. XenFI is comprised of XMD™ (a HIPAA-compliant, global healthcare cloud) and its XenFI-Hub™, Xenter’s wireless communications device that is designed for use […]
Xenter Appoints Former Zimmer Biomet Exec as CFO
October 18, 2021 09:00 AM Eastern Daylight Time SALT LAKE CITY—Xenter this week announced that it has appointed Tony Collins as chief financial officer. Collins most previously served as CFO of the global business group at Zimmer Biomet and was responsible for all strategic and financial planning, business development, accounting and internal controls. He has held […]
Health Innovation Matters Podcast
Xenter, Inc. Purchases RORγT Clinical Program; Launches Xenter Therapeutics Business Unit Led by David J. Bearss, PhD
–Xenter Therapeutics Joins Xenter Hospital Technologies as New Business Unit to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health– June 23, 2021 07:00 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Following the close of $12M in Series A funding, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, announced the launch of […]
Xenter, Inc. Continues Rapid Expansion with Appointment of Scott Heuler, SVP of Global Sales and Marketing, and Gary Baldwin as CTO
–Xenter Continues Rapid Expansion to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health– For Immediate Release, May 20 2021, Salt Lake City –On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment […]
Xenter, Inc. Appoints Industry Leaders Robert S. Langer, Elazer R. Edelman, David J. Bearss and Mark Stautberg to Board of Directors; Closes $12M Series A
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health-May 07, 2021 11:26 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the […]
James R. Tobin, Former CEO of Boston Scientific, Joins Xenter, Inc. Board of Directors to Assist in Advance of Device/Data/Drug Technologies
-Xenter’s next-generation technology advances interventional medicine by integrating functions that formerly required multiple devices- For Immediate Release, April 27 2021, Salt Lake City – On the heels of its April 7 launch announcement, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced that James R. Tobin has been appointed to the […]
